← Open Payments lookup

KELLY HAMMILL: Open Payments

NPI 1003381062 · YPSILANTI, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$822 in 19 payments from 6 companies in 2025. Trend: 2023 $697 · 2024 $562 · 2025 $822

Food & beverage: $822
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.10$403
ABBVIE INC.2$148
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$146
Neurocrine BioSciences, Inc.2$55
Supernus Pharmaceuticals, Inc.2$47
Alkermes, Inc.1$24

Products named: REXULTI, ABILIFY MAINTENA, VRAYLAR, CAPLYTA, INGREZZA, Qelbree, ABILIFY ASIMTUFII, ARISTADA.

Industry payments across MI — which companies pay providers there.